Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial
about
Oral anticoagulants versus antiplatelet therapy for preventing stroke in patients with non-valvular atrial fibrillation and no history of stroke or transient ischemic attacksNew insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolismSystematic review and network meta-analysis of stroke prevention treatments in patients with atrial fibrillation.The Benefit and Safety of Aspirin for Primary Prevention of Ischemic Stroke: A Meta-Analysis of Randomized TrialsAsian strategy for stroke prevention in atrial fibrillationLone atrial fibrillation: where are we now?Patients with atrial fibrillation and outcomes of cerebral infarction in those with treatment of warfarin versus no warfarin with references to CHA2DS2-VASc score, age and sex - A Swedish nationwide observational study with 48 433 patients.Risk analysis of new oral anticoagulants for gastrointestinal bleeding and intracranial hemorrhage in atrial fibrillation patients: a systematic review and network meta-analysis.Oral anticoagulation in elderly patients as secondary prevention of cardioembolic strokesSafety and efficacy of switching anticoagulation to aspirin three months after successful radiofrequency catheter ablation of atrial fibrillation.A comparison of risk stratification schemes for stroke in 79,884 atrial fibrillation patients in general practice.Effect of pharmacological therapies for stroke prevention on major gastrointestinal bleeding in patients with atrial fibrillation.Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort study.Performance of stroke risk scores in older people with atrial fibrillation not taking warfarin: comparative cohort study from BAFTA trialSystematic review of observational studies assessing bleeding risk in patients with atrial fibrillation not using anticoagulants.How to walk the tightrope between harm and protection in selecting the optimal antiplatelet treatment strategy after transcatheter left atrial appendage occlusionAntithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.Review of atrial fibrillation outcome trials of oral anticoagulant and antiplatelet agents.Stroke Prevention in Atrial Fibrillation: Where are We Now?Preventing stroke in atrial fibrillation patients - clinical utility of oral anticoagulants.Stroke prevention in atrial fibrillation: understanding the new oral anticoagulants dabigatran, rivaroxaban, and apixabanStroke prevention in atrial fibrillation: concepts and controversiesAnticoagulation in Atrial FibrillationNovel oral anticoagulants for stroke prevention in atrial fibrillation: a focus on the older patientCHADS2 versus CHA2DS2-VASc score in assessing the stroke and thromboembolism risk stratification in patients with atrial fibrillation: a systematic review and meta-analysis.New Stroke Prophylaxis Options in Atrial Fibrillation Patients.Improving anticoagulation in atrial fibrillation: observational study in three primary care trusts.Aspirin dosing for the prevention and treatment of ischemic stroke: an indication-specific review of the literature.Stroke prevention in atrial fibrillation patients.Lone atrial fibrillation: what is known and what is to come.Prediction of stroke risk in atrial fibrillation, prevention of stroke in atrial fibrillation, and the impact of long-term monitoring for detecting atrial fibrillation.Can we predict stroke in atrial fibrillation?Antithrombotic therapy for stroke prevention in atrial fibrillation and mechanical heart valves.Aspirin in stroke prevention in nonvalvular atrial fibrillation and stable vascular disease: an era of new anticoagulants.The impact of antiplatelet and anticoagulant therapies on gastrointestinal symptoms in patients with atrial fibrillation: a systematic review.The challenge of antiplatelet therapy in patients with atrial fibrillation and heart failure.Stop the clots, but at what cost? Pharmacoeconomics of dabigatran etexilate for the prevention of stroke in subjects with atrial fibrillation: a systematic literature review.Screening, isolation, and decolonization strategies for vancomycin-resistant enterococci or extended spectrum Beta-lactamase-producing organisms: a systematic review of the clinical evidence and health services impact.Review of challenges in optimizing oral anticoagulation therapy for stroke prevention in atrial fibrillation.Current and new oral antithrombotics in non-valvular atrial fibrillation: a network meta-analysis of 79 808 patients.
P2860
Q24244298-5B35C56D-23DD-464F-8746-71363A0BA2CEQ26786574-D228CDF2-4650-492C-A364-AFE502671ACEQ27337981-DEECE5C8-AA20-4B2B-897F-A788434F7AF0Q28066973-DFBF38CC-E9EF-4674-A550-951C9D100F6FQ28072723-989227BA-C1C4-4703-8787-5D7DE72CA770Q30409016-79FA3C5B-1EC5-45AD-8E38-CAF7A8B251D3Q33637662-D33DFE22-10E2-43DF-AF38-EFABFEF36F93Q33876319-AC972674-2B04-4CD4-914E-EF1FC3A9DF43Q33933527-9C17269D-DB9D-43E8-9A9F-BA77326A2F0DQ33941583-E960A4EC-7F5F-4F95-BE61-D94AF16F8FA9Q34146593-E2F88CDF-5A5C-4B6E-BC76-3751978958A8Q34233473-7D7449F2-800E-4FB9-9F84-D98EB4CCB3C3Q34540479-10892644-845E-4740-BE22-83E271B2EC3FQ35062723-020A90DF-FF5E-415A-B698-967EE7CB26CCQ35093560-D1CB158F-40AD-49B2-A1D3-4E724F954038Q35214488-D879A02E-0692-43B4-BDD7-CF435735554EQ35752573-83440EAB-0943-4C3C-B867-F791B5043F55Q35768553-6329D398-DA71-4EB9-AF1C-3613A2E16546Q35811581-497C72E5-1409-4FD2-BA90-D081EEECEC5BQ35938914-7E8FCB4E-07E8-4115-B9E4-16028C8B4384Q36241389-DFF33A96-6239-4E74-BABC-D7E18F36398EQ36382375-EA7C1E5C-5FAD-464D-B4F3-EE1D166538ACQ36458782-8F5E136E-631A-47FA-A2B4-CD937A34AC4FQ36723401-35987EEE-552E-4B4A-A5EB-3D20C769A1CCQ37229922-15DBE914-3281-4115-98E1-82C9905C5644Q37495909-EED3C6BC-EE24-4BF8-9E74-D1621C0BC808Q37725772-9140C7EB-7C2B-49DF-80D2-60BB0346142DQ37730309-16C2BD49-60DA-4B2B-BA56-58CB78B9711EQ37780750-9B822D37-E51F-46AF-A6A6-CA3FB7BFF3D3Q37827195-88402AD4-FFB5-4170-8BD2-430976E5C060Q37885792-2B4CE072-84B3-4DF3-8991-45ACFA300064Q37975986-1CD6ECB9-3658-49FB-B45C-FD30F1584FD0Q37990454-DC85901D-D82B-4BEC-89A7-C6305F7AC8E2Q37998110-6B693CF4-E3C8-4636-8F16-B9812EF0BDA9Q38038960-BBD0C72C-98BA-4F1A-B70F-F0BA3DA208ABQ38064758-91594C63-F628-4631-A114-A8E45859BE80Q38080912-10DC1788-AA30-4D0A-811E-963660812F69Q38086826-3E1FC31D-E571-4756-BA1F-1D8F460320D8Q38097727-C456790F-C008-447B-A745-F00E2ADF2866Q38134680-AE4DFE52-9322-4457-A676-D0662D3F1284
P2860
Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial
description
2006 nî lūn-bûn
@nan
2006 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Low-dose aspirin for preventio ...... rial Fibrillation Stroke Trial
@ast
Low-dose aspirin for preventio ...... rial Fibrillation Stroke Trial
@en
Low-dose aspirin for preventio ...... rial Fibrillation Stroke Trial
@nl
type
label
Low-dose aspirin for preventio ...... rial Fibrillation Stroke Trial
@ast
Low-dose aspirin for preventio ...... rial Fibrillation Stroke Trial
@en
Low-dose aspirin for preventio ...... rial Fibrillation Stroke Trial
@nl
prefLabel
Low-dose aspirin for preventio ...... rial Fibrillation Stroke Trial
@ast
Low-dose aspirin for preventio ...... rial Fibrillation Stroke Trial
@en
Low-dose aspirin for preventio ...... rial Fibrillation Stroke Trial
@nl
P2093
P3181
P1433
P1476
Low-dose aspirin for preventio ...... rial Fibrillation Stroke Trial
@en
P2093
Akira Kitabatake
Hideki Origasa
Hiroshi Sato
Katsuhiko Hiramori
Kinji Ishikawa
Kiyoshi Yoshida
Masatsugu Hori
Masayasu Matsumoto
Noboru Takekoshi
Satoshi Ogawa
P304
P3181
P356
10.1161/01.STR.0000198839.61112.EE
P407
P577
2006-02-01T00:00:00Z